Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Paxlovid Cuts Covid Death Risk. But Those Who Need It Are Not Taking It.

With Covid deaths rising to about 1,500 per week, researchers question why Paxlovid use has remained low among high-risk patients.

Christina Jewett
Author: Christina Jewett

Written by

Christina Jewett

in

Drugs (Pharmaceuticals), Elderly, National Institutes of Health, Paxlovid (Drug), Pfizer Inc, Research, United States
←WATCH: In My Feed – Celebrity Breakups In 2023 That Shocked Us All
WATCH: In My Feed – Films To Watch This Year→

More posts

  • The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

  • Questions rise over primary polls following Michigan, Wisconsin upsets

  • Sevastopol blast kills Russian service member, state media says

  • Zero hours crackdown could cost firms up to £2.9bn a year

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube